Chun‐Feng Liu

30.2k total citations · 3 hit papers
553 papers, 9.9k citations indexed

About

Chun‐Feng Liu is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Chun‐Feng Liu has authored 553 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Neurology, 127 papers in Epidemiology and 105 papers in Molecular Biology. Recurrent topics in Chun‐Feng Liu's work include Parkinson's Disease Mechanisms and Treatments (138 papers), Neurological disorders and treatments (42 papers) and Acute Ischemic Stroke Management (38 papers). Chun‐Feng Liu is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (138 papers), Neurological disorders and treatments (42 papers) and Acute Ischemic Stroke Management (38 papers). Chun‐Feng Liu collaborates with scholars based in China, United States and Australia. Chun‐Feng Liu's co-authors include Li‐Fang Hu, Fen Wang, Chengjie Mao, Yaping Yang, Yongjun Cao, Shoujiang You, Xingshun Xu, Yanlin Zhang, Yali Wang and Yun Shen and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.

In The Last Decade

Chun‐Feng Liu

519 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circadian disruption and sleep disorders in neurodegeneration

2023 80 citations Yun Shen, Sheng Zhuang et al. profile →
Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho‐1/Gpx4 pathway to prevent α‐synuclein‐induced ferroptosis in Parkinson's disease

2024 46 citations Chun‐Feng Liu et al. profile →
Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice

2025 16 citations Wenyu Gong, Lu Gan et al. International Immunopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chun‐Feng Liu China	51	2.9k	2.2k	2.0k	1.5k	1.4k	553	9.9k
Gang Chen China	61	4.9k 1.7×	3.4k 1.6×	2.1k 1.0×	1.1k 0.8×	2.6k 1.9×	415	12.7k
Zhong Wang China	50	2.8k 1.0×	1.6k 0.7×	1.5k 0.8×	648 0.4×	995 0.7×	380	8.2k
Jianmin Zhang China	56	3.1k 1.1×	2.7k 1.2×	1.6k 0.8×	775 0.5×	1.8k 1.4×	392	10.5k
Guanghui Wang China	61	6.6k 2.3×	1.7k 0.8×	2.0k 1.0×	1.1k 0.7×	803 0.6×	415	12.8k
Norihiro Suzuki Japan	66	4.8k 1.7×	4.6k 2.1×	2.2k 1.1×	2.5k 1.6×	1.7k 1.2×	749	17.7k
Robert N. Weinreb United States	106	7.8k 2.7×	1.7k 0.8×	2.6k 1.3×	1.3k 0.8×	2.4k 1.8×	1.1k	50.1k
Soon‐Tae Lee South Korea	56	4.2k 1.5×	3.2k 1.5×	1.5k 0.8×	1.1k 0.7×	1.3k 0.9×	341	12.9k
Pramod K. Dash United States	65	5.1k 1.8×	3.0k 1.4×	2.0k 1.0×	878 0.6×	1.2k 0.9×	261	13.0k
Johannes Klein Germany	51	1.7k 0.6×	2.3k 1.1×	2.6k 1.3×	2.8k 1.8×	550 0.4×	185	10.2k
Yuchuan Ding United States	50	2.1k 0.7×	2.8k 1.3×	2.6k 1.3×	897 0.6×	2.7k 2.0×	422	10.3k

Countries citing papers authored by Chun‐Feng Liu

Since Specialization

Citations

This map shows the geographic impact of Chun‐Feng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Feng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Feng Liu more than expected).

Fields of papers citing papers by Chun‐Feng Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Feng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Feng Liu. The network helps show where Chun‐Feng Liu may publish in the future.

Co-authorship network of co-authors of Chun‐Feng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Feng Liu. A scholar is included among the top collaborators of Chun‐Feng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Feng Liu. Chun‐Feng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Fang, et al.. (2025). MiR-182 ameliorates neuropathic pain by enhancing the transition from M1 to M2 phenotype polarization via PI3K/AKT signaling. Folia Neuropathologica. 63(3). 269–281.

Huang, Yuxuan, Zhaoxia Wang, Chun‐Feng Liu, et al.. (2025). The mTOR Signaling Pathway: Key Regulator and Therapeutic Target for Heart Disease. Biomedicines. 13(2). 397–397. 7 indexed citations

Wu, Jiajing, Sheng Zhuang, Fan Gao, et al.. (2025). Clinical Effect on Cortical Reactivity of Theta Burst Versus High‐Frequency Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease: A TMS‐EEG Study. CNS Neuroscience & Therapeutics. 31(9). e70605–e70605.

Gong, Wenyu, Lu Gan, Yikun Zhu, et al.. (2025). Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice. International Immunopharmacology. 147. 113937–113937. 16 indexed citations breakdown →

You, Shoujiang, Danni Zheng, Xiaoying Chen, et al.. (2025). Subacute Neurological Improvement Predicts Favorable Functional Recovery After Intracerebral Hemorrhage: INTERACT2 Study. Stroke. 56(3). 621–627. 2 indexed citations

Li, Shimeng, Zhichao Liu, Xiaodan Jiao, et al.. (2024). Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway. Biochemical Pharmacology. 225. 116282–116282. 2 indexed citations

Liu, Sha, Mingxuan Zheng, Xing Ge, et al.. (2024). Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease. Neural Regeneration Research. 19(9). 2081–2088. 18 indexed citations

Chen, Shuang, et al.. (2024). Attention-enhanced dilated convolution for Parkinson’s disease detection using transcranial sonography. BioMedical Engineering OnLine. 23(1). 76–76. 2 indexed citations

Liu, Chun‐Feng, et al.. (2024). Encephalitis with Antibodies Against Glial Fibrillary Acidic Protein (GFAP) After Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report and Literature Review. Journal of Blood Medicine. Volume 15. 359–362.

10.

Liu, Chun‐Feng, et al.. (2024). Synergistic Strength–Ductility Improvement in an Additively Manufactured Body-Centered Cubic HfNbTaTiZr High-Entropy Alloy via Deep Cryogenic Treatment. Micromachines. 15(8). 937–937.

11.

Yang, Xuezhi, et al.. (2024). A new machine learning model to predict the prognosis of cardiogenic brain infarction. Computers in Biology and Medicine. 178. 108600–108600. 1 indexed citations

12.

Wu, Jiayu, Yiming Wang, Yuan Yuan, et al.. (2024). Changes in slow-wave sleep characteristics in Parkinson's disease patients with mild-moderate depression. Sleep Medicine. 121. 219–225. 1 indexed citations

13.

Qiu, Huijun, Chun‐Feng Liu, Qingwu Wu, et al.. (2024). An in vitro study of the impact of IL-17A and IL-22 on ciliogenesis in nasal polyps epithelium via the Hippo-YAP pathway. Journal of Allergy and Clinical Immunology. 154(5). 1180–1194. 7 indexed citations

14.

Fang, Yuan, Chun‐Feng Liu, Borui Zhang, et al.. (2024). A systematic review of the benefits and mechanisms of family-based mind-body therapy programs targeting families of children and adolescents with attention-deficit/hyperactivity disorder. Journal of Social and Personal Relationships. 41(8). 2219–2250.

15.

Liu, Junyi, Dongqin Chen, Manhua Liu, et al.. (2023). How sleep quality affects activities of daily living in Parkinson’s disease: the mediating role of disease severity and the moderating role of cognition. Frontiers in Aging Neuroscience. 15. 1238588–1238588. 2 indexed citations

16.

Xu, Jiaping, Lixuan Wang, Jiayun Wang, et al.. (2023). The prognostic value of deep earlobe creases in patients with acute ischemic stroke. Frontiers in Cardiovascular Medicine. 10. 1096044–1096044. 1 indexed citations

17.

Mao, Chengjie, Zhaohui Lu, Rongfang Shi, et al.. (2023). Sarcopenia is associated with non-motor symptoms in Han Chinese patients with Parkinson's Disease: a cross-sectional study. BMC Geriatrics. 23(1). 494–494. 6 indexed citations

18.

Shi, Jijun, Hao Peng, Shoujiang You, et al.. (2018). Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study. European Journal of Neurology. 25(4). 687–687. 45 indexed citations

19.

Zhang, Yuan, Jun Zhang, Dongsheng Jiang, et al.. (2012). Inhibition of T‐type Ca²⁺channels by endostatin attenuates human glioblastoma cell proliferation and migration. British Journal of Pharmacology. 166(4). 1247–1260. 88 indexed citations

20.

Shi, Jijun, Yaping Yang, Jun Li, et al.. (2011). HDAC6 regulates aggresome‐autophagy degradation pathway of α‐synuclein in response to MPP⁺‐induced stress. Journal of Neurochemistry. 117(1). 112–120. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact